Business · 01/03/2001Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Biological Products Information Collection
Summary
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information on biological product deviations in manufacturing, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →